Larsen & Toubro's Q3 results are expected to be strong, with a robust order book and reduced debt. The company's stock has gained 74.83% in the last year and 179% in the last five years. Analysts predict a 30% increase in net profit and a 20% growth in revenue. Improved margins and significant orders, including a contract to build a new medical institute, contribute to the positive outlook.